| Identification | Back Directory | [Name]
3-b-D-Ribofuranosyl-6-hydroxyMethyl-furano[2,3-d]-pyriMidin-2-one | [CAS]
1058167-74-0 | [Synonyms]
3-?-D-Ribofuranosyl-6-hydroxymethyl-furano[2,3-d]-pyrimidin-2-one
3-β-D-Ribofuranosyl-6-hydroxymethyl-furano[2,3-d]-pyrimidin-2-one
6-(Hydroxymethyl)-3-β-D-ribofuranosylfuro[2,3-d]pyrimidin-2(3H)-one
Furo[2,3-d]pyrimidin-2(3H)-one, 6-(hydroxymethyl)-3-β-D-ribofuranosyl-
6-(Hydroxymethyl)-3-beta-D-ribofuranosylfuro[2,3-d]pyrimidin-2(3H)-one
3-(β-D-ribofuranosyl)-6-hydroxymethyl-2,3-dihydrofurano[2,3-d]pyrimidin-2-one | [Molecular Formula]
C12H14N2O7 | [MDL Number]
MFCD20134038 | [MOL File]
1058167-74-0.mol | [Molecular Weight]
298.25 |
| Hazard Information | Back Directory | [Uses]
3-β-D-Ribofuranosyl-6-hydroxymethyl-furano[2,3-d]-pyrimidin-2-one is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
m.approvedhomemanagement.com/showsupplierproductslist1701258/0.htm |
|